InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (11 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
11
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Seshadri Vishwas, Chief Executive Officer. Officer active across 1 company, notably Abeona Therapeutics INC.. Aggregated, 31 reports have been recorded. Split: 3 buys · 11 sells. Total volume traded: €2m. Activity tracked since 1 June 2021. The latest transaction was disclosed on 9 July 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Seshadri Vishwas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations31 total
67,971 shares@ US$6.96370.12% mcap28.4% of flowCommon StockSEC:0001493152-26-032744:0
24,428 sharesCommon StockSEC:0001493152-26-028020:0
31,916 sharesCommon StockSEC:0001493152-26-028020:1
29,985 shares@ US$4.38490.039% mcap15.2% of flowCommon StockSEC:0001493152-26-014418:0
69,832 shares@ US$5.330911.6% of flowCommon StockSEC:0001493152-26-003283:0
365,422 shares0Common StockSEC:0001493152-26-002887:0
25,000 shares@ US$5.30964.7% of flowCommon StockSEC:0001493152-25-029384:0
249 shares@ US$5.4850.1% of flowCommon StockSEC:0001493152-25-018311:0
19,274 shares@ US$5.39353.8% of flowCommon StockSEC:0001493152-25-016543:0
69,420 shares@ US$5.855719.2% of flowCommon StockSEC:0001641172-25-018606:0
50,676 shares@ US$6.7620.5% of flowCommon StockSEC:0001641172-25-014172:0
885 shares@ US$6.240.7% of flowCommon StockSEC:0001641172-25-013428:0
25,000 shares@ US$4.7814.8% of flowCommon StockSEC:0001641172-25-001922:0
476,435 shares0Common StockSEC:0001493152-25-003463:0
251 shares@ US$6.540.2% of flowCommon StockSEC:0001493152-24-041421:0
18,798 shares@ US$5.8913.3% of flowCommon StockSEC:0001493152-24-038802:0
424,000 shares0Common StockSEC:0001493152-24-026642:0
38,621 shares@ US$4.5221.5% of flowCommon StockSEC:0001493152-24-023124:0
703 shares@ US$4.380.4% of flowCommon StockSEC:0001493152-24-022756:0
10,000 shares@ US$3.204.0% of flowCommon StockSEC:0001493152-24-016853:0
Canonical exit: 24 Jul 2024 (T+90)
20,000 shares@ US$4.3910.9% of flowCommon StockSEC:0001493152-24-005208:0
Canonical exit: 6 May 2024 (T+90)
181 shares@ US$4.140.1% of flowCommon StockSEC:0001493152-23-037500:0
13,290 shares@ US$3.9334.7% of flowCommon StockSEC:0001493152-23-034916:0
20,000 shares@ US$4.0754.4% of flowCommon StockSEC:0001493152-23-034741:0
Canonical exit: 26 Dec 2023 (T+90)
336,826 shares0Common StockSEC:0001493152-23-020417:0
25 of 31 declarations
About Seshadri Vishwas
Seshadri Vishwas is Director General and Chief Executive Officer at Abeona Therapeutics INC. He has 31 filings in total, and across the sampled recent filings from 2021-06-03 to 2026-07-09, the reported amounts are EUR 189045 in purchases and EUR 1805312 in sales, with the dominant transaction nature indicated as sale.
